News | September 26, 2012

New IMV Survey Shows Aging of Installed MR Scanners in the U.S.

Average age of installed MRI scanners in U.S. has increased, according to new market research report by IMV

IMV Medical Information Division MRI Systems Clinical Trial

September 26, 2012 — The average age of installed magnetic resonance imaging (MRI) scanners in the United States has increased from eight years in 2007 to 10.9 years in 2011, according to a new market research report by IMV Medical Information Division.

“The last spike of new MR installations extended from 2002 to 2004,” observed Lorna Young, senior director, market research at IMV. “The research finds that the MRI market is ready for replacement of the older units that are at the end of their useful lives. Providers are also planning to take advantage of the wider bore sizes that are now available."

Survey results indicate that two out of every three new MR installations will be wide-bore. Young noted that 1.5T units are still the mainstay of the modality, representing 70 percent of all recently installed MR scanners and 70 percent of all systems currently in place.

While overall procedures performed in the United States rose an estimated 6 percent to 32 million procedures from 2010 to 2011, utilization at the site level increased 4 percent and the average number of MR procedures performed per scanner fell 4 percent. Respondents reported that reductions in reimbursements, from both Medicare and third-party payors, caused their MR revenues to decline despite the slight increase in utilization.

Lower and upper extremity procedures grew 15 percent from 2010 to 2011, making these applications the biggest contributor to MR procedure growth, the research found. Other areas of MR procedure growth were orthopedic and neurological procedures.   

The risk of nephrogenic system fibrosis (NSF) remains a concern for providers considering the use of gadolinium-based contrast agents (GBCA). More than 75 percent of the survey respondents stated that NSF prevention is a priority patient-management issue for their departments.

The report describes trends in MR patient exams by procedure type, MR installed base by manufacturer and year of installation, planned purchases and market scenarios for unit sales through 2016, contrast media expenditures by supplier, site operations characteristics, and department managers' opinions about the factors affecting the future outlook for MR at their facility. Other report highlights include:

  • 63 percent of all MR studies were performed in hospitals or in hospital-owned imaging centers.
  • 22 percent of all MR users plan on purchasing a new system in the next three years.
  • 6 percent of all MR sites use a mobile service.
  • 37 percent of all MR procedures used contrast in 2011, declining from 42 percent in 2010.
  • Spine, brain, and lower and upper extremities comprised the four largest categories of MR procedures.


For more information: www.MReport.imvinfo.com

Related Content

First Patient Enrolled in U.S. Arm of ALIVE Pivotal Heart Failure Trial
News | Heart Failure| October 17, 2017
October 17, 2017 — BioVentrix Inc. recently announced enrollment of the first patient in the U.S.
FDA Clears Siemens Magnetom Terra 7T MRI Device

The FDA has cleared the Siemens Magnetom Terra as the first 7T MRI system in the U.S. to gain regulatory approval.

Technology | Magnetic Resonance Imaging (MRI)| October 12, 2017
The U.S. Food and Drug Administration (FDA) cleared the first 7 Tesla (7T) magnetic resonance imaging (MRI) device,...
Low Mortality and Stroke Risks Displayed for Minimally Invasive Aortic Valve Replacements
News | Heart Valve Technology| October 11, 2017
An analysis of more than 1,000 minimally invasive aortic valve replacements and more than 400 additional associated...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI)| October 11, 2017
MR Solutions took their cryogen-free preclinical multimodality magnetic resonance imaging (MRI) solutions on tour in...
New Evaluation Sends Low-Risk ER Chest Pain Patients Home Sooner
News | Cardiac Diagnostics| October 10, 2017
A new evaluation to determine whether emergency room patients with chest pain can go home and follow up with their...
News | Pharmaceuticals| October 04, 2017
October 4, 2017 — MyoKardia Inc.
Medtronic Announces Post-Market Study for CoreValve Evolut Pro System
News | Heart Valve Technology| October 02, 2017
Medtronic plc recently announced a new post-market clinical study to evaluate its CoreValve Evolut Pro valve in...
Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD)| September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
BioCardia Announces 12-Month Results from TRIDENT Trial of Stem Cell Delivery System
News | Stem Cell Therapies| September 26, 2017
BioCardia Inc. recently announced 12-month results from the Phase II TRIDENT clinical trial, conducted by the...
News | Vena Cava Filters| September 26, 2017
September 26, 2017 — The one-year results of the SENTRY...
Overlay Init